AGRX11 unit holder: what does this mean for you right now?
The biggest risk flagged in the June 2026 analysis -- the Agrosepac CRA (Brazilian agricultural receivables certificate) in declared early maturity -- has been resolved. The company sold one of the farms pledged as collateral, cleared the overdue installments and even prepaid future ones; the early maturity was suspended and the credit returned to performing status, with the next interest payment scheduled for September 2026. As a result, the rating moves back from 5.0 to 5.5 (NEUTRAL). In practice: current holders should stay in; at R$ 8.51, the fund trades at P/NAV of 0.82 (roughly 18% discount) and yields approximately 17.4% over 12 months. This is not a panic-sell moment, nor is it an obvious bargain -- the remaining risk has a clear name: Hinove and a falling Selic (Brazil's benchmark rate).
What the new document revealed
AGRX11 is a paper-based Fiagro (Brazilian agricultural credit fund): instead of buying farmland directly, it purchases agribusiness credit instruments -- mainly CRAs (agricultural receivables certificates) -- and passes the interest income to unit holders. That is why the dividend yield is elevated, but the flip side is credit risk. Credit risk was exactly what dominated the previous analysis, when the monthly disclosure revealed R$ 50.3 million in assets overdue by 31 to 90 days, with the Agrosepac CRA under declared early maturity.
The May 2026 management report provides the resolution of that central episode: Agrosepac has been settled. And the way it happened matters as much as the outcome itself.
How early maturity works -- and why this resolution validates the thesis
When a borrower breaches a contract -- misses installments or violates covenants -- the fund manager can declare early maturity: instead of waiting for monthly payments, the entire outstanding balance is called at once and the manager moves to enforce the collateral. It is a serious stage, but it is also the moment of truth for whether the real-asset guarantees pledged in the contract actually convert to cash.
With Agrosepac, they did. The company sold one of the farms it had pledged as collateral, used the sale proceeds to settle all overdue amounts and even prepaid future installments. Outcome: the early maturity was suspended, the CRA returned to performing status, and the next interest payment is scheduled for September 2026.
This is more than a one-off positive event. It is a proof of concept for the real-collateral thesis: AGRX11's CRAs carry fiduciary liens on rural real estate well above the outstanding balance, and the open question was always whether, under stress, those assets would actually convert to cash. In Agrosepac's case they did -- through a negotiated sale, not a slow judicial auction. Credit goes to asset manager Exes Gestora de Recursos for executing the guarantee competently, following the same playbook as the CRA Valeria recovery (fully recouped in 2025).
The risk that remains: Hinove
With Agrosepac resolved, the main credit watch item shifts to CRA Hinove (specialty fertilizers), which represents 8.8% of NAV -- approximately R$ 16.3 million.
Hinove is currently operating under a covenant waiver. A covenant is a contractual clause requiring the borrower to maintain certain financial health indicators. Hinove closed the period with a current ratio of 0.84x, below the contractual minimum of 1.20x -- meaning it held less short-term liquidity than required to cover its immediate obligations. A waiver is a temporary exemption from that breach, approved in a unit-holder assembly, preventing the automatic trigger of early maturity.
Two concrete mitigating factors apply. First, the short duration (1.29 years): the instrument matures naturally in 2027, so even if the company remains under pressure, the exposure window is limited. Second, the real collateral structure -- identical to Agrosepac's, which just demonstrated its practical value. The risk is not trivial (it is the largest remaining credit exposure), but it is mapped, short-dated, and backed by tangible assets. This is an amber light, not red.
Worth noting what does not change: the CRA Agrogalaxy remains provisioned at 99% since December 2025 (company in judicial reorganization). That is already priced into NAV -- no fresh surprise is expected from it, and the residual balance is immaterial.
Elevated cash and the first reinvestment (CPR Renato)
A side effect of resolving credit problems is that cash piles up. With the Agrosepac settlement and other amortizations, the fund parked R$ 31.0 million in BTG Yield DI -- 16.7% of NAV, well above the historical norm of around 6%.
Cash sitting in an overnight DI fund earns a return, but it earns less than the portfolio's CRAs: it is a return drag until it is redeployed into agricultural credit. The good news is that the manager has already taken the first step: it structured the CPR Renato -- CDI (interbank overnight rate) plus 9%, R$ 4.5 million, 2-year term, backed by rural real estate collateral appraised at 550% of the outstanding balance. It is an attractively priced operation with ample collateral coverage -- exactly the profile the fund needs to recycle idle cash. The work ahead is repeating that a few more times to bring the cash allocation back to normal levels and restore the portfolio's average return.
Selic pressure on portfolio carry
With roughly 85% of the portfolio indexed to CDI+, AGRX11 is directly sensitive to the Selic -- and the Selic is coming down. The portfolio's average spread contracted from CDI plus 5.5% (Apr/26) to CDI plus 5.1% (May/26), and the monthly interest accrual fell from R$ 2.28 million to R$ 2.09 million over the same period.
The mechanism is straightforward: lower accrued interest means less fuel for the dividend. The current DPS is R$ 0.12/unit per month (next payment July 15, 2026, referencing June), still supported by an accumulated reserve of R$ 0.26/unit (approximately 2 months of DPS). The structural trend -- regardless of credit developments -- is mild pressure on distributions as long as the Selic continues declining. Redeploying the elevated cash into operations like CPR Renato helps offset part of this squeeze.
Current risk watch items
| Item | % of NAV | Status |
|---|---|---|
| CRA Agrogalaxy (provisioned) | ~1% | 99% provision since Dec/25 -- no new surprise expected |
| CRA Hinove | 8.8% | Covenant waiver (current ratio 0.84x vs 1.20x). Duration 1.29yr, matures 2027 |
| Declining portfolio yield | -- | CDI+5.1% (May) vs CDI+5.5% (Apr); accrual fell to R$ 2.09M/month |
| Elevated cash (BTG Yield DI) | 16.7% | Return drag; CPR Renato was the first redeployment |
| Top-10 concentration | -- | Cash 16.7% · Exes Terras 10.3% · Orbi 10.0% · Celeste 9.4% · Hinove 8.8% |
| Secondary market liquidity | -- | ~R$ 332k/day; orders above R$ 100k move the price |
| Agrosepac (resolved) | 6.4% | Farm sold, arrears cleared, back to performing. Interest due Sep/26 |
Where the price fits in
At R$ 8.51, AGRX11 trades at a P/NAV of 0.82 -- an 18% discount to the book value of R$ 10.38. Part of that discount reflects the market pricing in residual credit risk (Hinove) and the Agrogalaxy provision already recognized. But the manager's own carry table (May/26 management report) shows that buying at R$ 8.50 embeds an implied return of CDI plus 13.81% -- signaling that the discount compensates for most of the remaining risks for investors willing to hold the instrument.
Among paper-based Fiagros (Brazilian agricultural credit funds), AGRX11 is a mid-size fund -- more concentrated and less liquid than larger peers such as RZAG11. That is not a flaw in itself; it is the profile of a fund that bets on proprietary origination of agricultural credit with robust real-collateral backing. The Agrosepac resolution strengthens the case that this bet has executable substance. What remains to be seen is whether Hinove delivers the same outcome and whether the manager successfully redeploys the idle cash into CPR Renato-caliber operations.
Verdict: NEUTRAL -- Rating 5.5/10 (was 5.0, HOLD). The rating rises 0.5 point because the main risk from the previous analysis -- Agrosepac in early maturity -- was resolved through collateral enforcement (farm sale), validating in practice the thesis that the CRAs carry real, convertible collateral. The concrete remaining risks are the CRA Hinove (8.8% of NAV, covenant waiver, but short duration maturing in 2027) and the structural pressure of a falling Selic on portfolio carry. The ~18% discount to NAV and the implied carry of CDI plus 13.81% compensate for most of those risks.
For current holders: hold -- the picture has improved since June. For new entrants: consider a gradual position, with full awareness of the remaining risks (Hinove and Selic trajectory). It is not an obvious bargain, nor a trap -- it is an honest NEUTRAL.
